{"id":"W4293462875","doi":"10.1093/eurheartj/ehac361","title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1297,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Western University; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Genentech; Regeneron Pharmaceuticals; Mylan; National Institutes of Health; Esperion Therapeutics; Gilead Sciences; Servier; Daiichi-Sankyo; Agence Nationale de la Recherche; Quest Diagnostics; Ionis Pharmaceuticals; AstraZeneca; Amarin Corporation; Boston Scientific Corporation; Silence Therapeutics; Kowa Company; European Atherosclerosis Society; Sanofi; Amgen; Pfizer; Eli Lilly and Company; World Heart Federation; Amryt Pharma; U.S. Department of Veterans Affairs","keywords":"Medicine; Lipoprotein(a); Internal medicine; Risk factor; Cardiology; Familial hypercholesterolemia; Lipoprotein; Cholesterol","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0438328079251105,"score_gpt":0.2639777590560184,"score_spread":0.2201449511309079,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}